MENU
ALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Altimmune (ALT) Earnings Date & Reports
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases... Show more
Industry: #Miscellaneous Commercial Services
A.I. Advisor
published Earnings
ALT is expected to report earnings to rise 13.00% to -13 cents per share on November 10
Q3'26
Est.
$-0.14
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.06
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.06
The last earnings report on August 12 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 4.20M shares outstanding, the current market capitalization sits at 604.95M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
57
Web
https://www.altimmune.com